Cortelazzo, Sergio
Regional Hospital of Bolzano,
Italy
2025 Rank: 80404
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2209 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80404 | 88469 |
| Total Cites | 8456 | 9507 |
| H-index | 45 | 47 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 430 | 434 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2067 | 2206 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 2597 | 2768 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7227 | 7901 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.20 |
| Self-Citation Percentage |
11.06%
|
|
Cortelazzo, Sergio
Humanitas Gavazzeni Hospital,
Italy
2024 Rank: 77996
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2186 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77996 | 84550 |
| Total Cites | 8032 | 9031 |
| H-index | 44 | 46 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 423 | 427 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 2004 | 2137 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2499 | 2662 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6854 | 7489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.21 |
| Self-Citation Percentage |
11.06%
|
|
Cortelazzo, Sergio
Humanitas Gavazzeni Hospital,
Italy
2023 Rank: 74402
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2129 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74402 | 80538 |
| Total Cites | 7638 | 8610 |
| H-index | 44 | 46 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 413 | 417 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1933 | 2065 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2405 | 2566 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6507 | 7124 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.21 |
| Self-Citation Percentage |
11.29%
|
|
Cortelazzo, Sergio
Humanitas Gavazzeni Hospital,
Italy
2022 Rank: 70771
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2078 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70771 | 78315 |
| Total Cites | 7136 | 8053 |
| H-index | 42 | 44 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 400 | 404 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1835 | 1962 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2271 | 2423 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6060 | 6642 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
11.39%
|
|
Cortelazzo, Sergio
Humanitas Gavazzeni Hospital,
Italy
2021 Rank: 69713
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2042 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69713 | 77523 |
| Total Cites | 6854 | 7748 |
| H-index | 41 | 43 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 394 | 398 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 1769 | 1891 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 2187 | 2334 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5822 | 6390 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
11.54%
|
|
Cortelazzo, Sergio
Ospedale Regionale,
Italy
2020 Rank: 66978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1967 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66978 | 73299 |
| Total Cites | 6343 | 7177 |
| H-index | 40 | 42 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 382 | 386 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1682 | 1801 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 2052 | 2196 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5356 | 5882 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
11.62%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.